Background/Aims Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide. Despite identification of several biomarkers for HCC diagnosis, challenges such as low sensitivity and intratumoral heterogeneity have impeded early detection, highlighting the need for etiology-specific blood biomarkers.
Methods We generated whole-transcriptome sequencing (WTS) and targeted proteome data from buffy coat and plasma samples from HCC patients. By integrating etiological information on viral infection, we investigated the etiology-specific gene expression landscape at the blood level. Validation of differentially expressed genes (DEGs) was performed using publicly available RNA-seq datasets and qRT‒PCR with AUC analyses.
Results Differential expression analyses with multiomics data revealed distinct gene expression profiles between HBV-associated HCC and nonviral HCC, indicating the presence of etiology-specific blood biomarkers. The identified DEGs were validated across multiple independent datasets, underscoring their utility as biomarkers. Additionally, single-cell RNA-seq analysis of HCC confirmed differences in DEG expression across distinct immune cell types.
Conclusions Our buffy coat WTS data and plasma proteome data may serve as reliable sources for identifying etiology-specific blood biomarkers of HCC and might contribute to discovery of therapeutic targets for HCC across different etiologies.
Citations
Citations to this article as recorded by
Relevance of proteomics and metabolomics approaches to overview the tumorigenesis and better management of cancer Pooja Singh, Yashika W. Dhir, Shagun Gupta, Ankur Kaushal, Deepak Kala, Rupak Nagraiik, Naveen K. Kaushik, Md Salik Noorani, Abdul R. Asif, Bharat Singh, Shahbaz Aman, Sunny Dhir 3 Biotech.2025;[Epub] CrossRef
Development of a big data platform for collecting and utilizing clinical information from the Korea Biobank Network Yun Seon Im, Seol Whan Oh, Ki Hoon Kim, Wona Choi, In Young Choi BMC Medical Informatics and Decision Making.2025;[Epub] CrossRef
Harnessing plasma transcriptomics for non-invasive cancer biomarker identification: a comprehensive review Nur Mazidah Haji Noor Mohamed, Nurulisa Zulkifle, Siti Razila Abdul Razak Discover Oncology.2025;[Epub] CrossRef
Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: A gateway to personalized medicine: Editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma” Joseph C. Ahn, Ju Dong Yang Clinical and Molecular Hepatology.2024; 30(4): 689. CrossRef
Technology and Future of Multi-Cancer Early Detection Danny A. Milner, Jochen K. Lennerz Life.2024; 14(7): 833. CrossRef
Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma” Su Bin Lim, Hyo Jung Cho Clinical and Molecular Hepatology.2024; 30(4): 1009. CrossRef
First
Prev
